Pharma Research Product invests W30.1b in BIOCND
[DISCLOSURE] Pharma Research Products (214450) announced on Jan. 23 that it has decided to acquire 48.74 percent stake (1,695,558 shares) in pharmaceutical product company BIOCND at 30.1 billion won (US$28.12 million) “to diversify business and to create synergy.”
This amounts to 17.45 percent of its equity capital.
By Hwang You-mee (glamazon@heraldcorp.com)